ANGPTL4 mutation ties lower triglycerides to lower CAD risk
A genetic link between elevated triglycerides and coronary heart disease has been identified, opening up the possibility of a new treatment target.
Two separate studies have linked mutations in a... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - March 2, 2016 Category: Endocrinology Source Type: news
AARP: Retail drug prices rising faster than inflation
Retail prices for medications used most commonly by Medicare patients rose almost 10% in 2013 – more than six times faster than the rate of inflation, according to an analysis by the AARP Public... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - March 2, 2016 Category: Endocrinology Source Type: news
CMS extends EHR hardship exemption deadline to July 1
Physicians and hospitals seeking a hardship exemption for not being able to meet meaningful use requirements in 2015 will have more time to file their application.
Applications for both groups are... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - March 2, 2016 Category: Endocrinology Source Type: news
Expert counsel: Selling a practice during a government investigation
AUSTIN,TEX. – There a lot of tough questions to answer when selling a medical practice during a government investigation, according to Morristown, N.J.–based health law attorney Glenn P. Prives.... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - March 2, 2016 Category: Endocrinology Source Type: news
HHS to doctors: We hear your health IT woes
LAS VEGAS – Federal officials have spent months listening to doctors’ complaints about their frustrating EHRs and are responding with a core group of changes to simplify and standardize health... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - March 2, 2016 Category: Endocrinology Source Type: news
Supreme Court: Self-funded insurer does not have to share data
A self-funded insurer does not have to share health data with a state’s all-payer database, according to a March 1 U.S. Supreme Court decision that could affect information-sharing reforms... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - March 1, 2016 Category: Endocrinology Source Type: news
Degludec/liraglutide noninferior to uptitrated glargine
For adults whose type 2 diabetes is not controlled by glargine plus metformin, switching from glargine to combination degludec/liraglutide lowered hemoglobin A1c levels to a noninferior... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - March 1, 2016 Category: Endocrinology Source Type: news
Romosozumab, coming ACR guidelines mark recent high points in osteoporosis
MAUI, HAWAII – The investigational bone-building agent romosozumab provided the therapeutic highlight in the field of osteoporosis during the past year, Dr. Martin J. Bergman said at the 2016... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - March 1, 2016 Category: Endocrinology Source Type: news
MRI topped transient elastography for staging nonalcoholic fatty liver disease
Two magnetic resonance imaging (MRI) techniques topped transient elastography (TE) for diagnosing hepatic fibrosis and steatosis in patients with nonalcoholic fatty liver disease (NAFLD), according... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - March 1, 2016 Category: Endocrinology Source Type: news
Feds: Major EHR companies will remove interoperability roadblocks
LAS VEGAS – Health care data interoperability should get a huge boost under a public-private effort announced Feb. 29 by U.S. Department of Health and Human Services Secretary Sylvia Burwell.
The... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - March 1, 2016 Category: Endocrinology Source Type: news
FDA calls for more safety data, patient counseling for Essure
The Food and Drug Administration has ordered Bayer to conduct a 2,000-patient postmarketing study of the Essure implantable birth control device, to explore the risks it may pose to some women and... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - February 29, 2016 Category: Endocrinology Source Type: news
DTC genomic tests: Some patients dissatisfied with physician interpretation
Twenty-seven percent of patients who purchased direct-to-consumer personal genomic testing in a large cohort study shared their results with their primary care providers, often looking for him or her... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - February 29, 2016 Category: Endocrinology Source Type: news
Review shows small benefit, significant safety concerns for flibanserin
A meta-analysis of eight clinical trials of the newly approved female hypoactive sexual disorder drug flibanserin show the drug yields minimal benefit, while increasing the risk of dizziness,... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - February 29, 2016 Category: Endocrinology Source Type: news
VIDEO: Beware legal land mines when working with PAs, NPs
AUSTIN, TEX. – As use of mid-level providers grows, legal risks for practices also can rise.
In this video interview at an American Health Lawyers Association conference, attorney <a... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - February 25, 2016 Category: Endocrinology Source Type: news
AMA’s Stack ‘cautiously optimistic’ about MACRA implementation
WASHINGTON – Coming regulations to implement the MACRA legislation also could include sweeping reforms to meaningful use and quality reporting programs, said Dr. Steven J. Stack, president of the... (Source: Clinical Endocrinology News)
Source: Clinical Endocrinology News - February 24, 2016 Category: Endocrinology Source Type: news
